Total Funding
52
8
Total FundingSeed raised
Growth Score 52 in past quarter
-7 pts
Heat Score 8 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
40089
Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..
David de Graaf: ChairpersonPast Role: Abcuro, President & CEO- Angele Maki: Board of DirectorsPast Role: Hummingbird Bioscience, CBO
About the Company
Ability biologics develops novel, tailored immune modifying biotherapeutics to address unmet medical requirements in cancer and autoimmune disease patients.